Evolva Acquires Resveratrol Programme From Fluxome
date:Dec 10, 2012
a 2012 Frost Sullivan report, sales of resveratrol at an ingredient level (for all applications) were c. USD 50 million in 2011, with double digit growth rates expected. Low purity Japanese Knotweed extracts, primarily from China, dominate the market. One company markets a synthetic product.

Evolva has agreed to acquire all of Fluxomes scientific and technical assets related to resveratrol and hire a small number of its employees, integrating the programme into Evolvas Danish operations. Evol
5/16 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
06/28 00:28